Medtronic commenced EU launch of AVILA™ devices, intended for use in open and minimally invasive anterior and oblique lumbar interbody fusion from L2-S1 levels.
On 4/20/16, FDA’s Orthopaedic and Rehabilitation Devices Panel will meet regarding the PMA for Cartiva’s Synthetic Cartilage Implant, an organic polymer-based biomaterial designed to mimic biologic cartilage.
OrthoSensor entered into a partnership with IM-Tech to support R&D collaboration, manufacturing and investments in electronics technology in the global commercialization of the VERASENSE™ sensor.
NuVasive entered into a definitive agreement to acquire Mega Surgical, its exclusive distributor in Brazil. The transaction is expected to close within 1Q16.
FDA has accepted for filing Vericel’s BLA for MACI™, matrix-applied characterized autologous cultured chondrocytes intended to treat adult symptomatic knee cartilage defects.
Stryker Spine announced FDA 510(k) clearance of Tritanium® PL, a highly-porous posterior lumbar cage manufactured via 3D additive manufacturing. Launch will occur in 2Q16.
DePuy Synthes entered into an exclusive strategic alliance with Value Stream Partners to facilitate customers’ implementation of bundled payment programs for hip and knee replacement.Â